About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
D
Improving Care in Advanced Ovarian Cancer: Can We Predict Who Will Have a Response and/or Recurrence to 1L Treatment? How Common Is PARPi Maintenance?
By
Dana Chase
2 Videos
349 views
May 21, 2021
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
27:04
Fengting Yan
Cancer Screening Molecular Tools
06:07
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Key Updates in Gynecological Cancers"
Feat.
M. Raza Mirza
06:50
Fengting Yan
Year in Review: Ovarian Cancer
11:15
Total Health
2024 Updates in Ovarian Cancer
Feat.
T. Tillmanns
25:10
Yale School of Medicine
Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …
Feat.
M. Minkin,
E. Ratner
06:23
Total Health
Recent Highlights in Ovarian Cancer
Feat.
B. Slomovitz
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
15:14
Brian Slomovitz
Update in Vulvar and Vaginal Cancer
28:11
OncoAlert
Ovarian Cancer: Setting a New Standard of Care
Feat.
M. Raza Mirza
18:16
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…
Feat.
J. Kurtz
14:05
Insights from 2023 ESGO Annual Meeting
ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comp…
Feat.
A. Clamp
23:35
Kathleen Moore
How to Select the Best Maintenance Treatment in Patients With Ovaria…
05:32
Insights from 2023 ESMO Asia Annual Meeting
LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…
Feat.
N. Ngoi
09:42
Erin Crane
Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer
05:09
Insights from 2024 SGO Annual Meeting
SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …
Feat.
N. Colombo
10:27
Robert McBane
2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…
11:37
UCLA Health
Recurrent Cervical Cancer Updates
Feat.
R. Salani
08:37
Fred Hutchinson Cancer Center
Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…
Feat.
K. Banda
17:06
Ovarian Cancer Midwest Focus, University of Minnesota
Novel ADCs in Ovarian Cancer: A New Treatment Modality
Feat.
S. Lheureux
11:02
SGO 2023 Conference Coverage on VuMedi
Chemoradiation for Stage IB3 Cervical Cancer
Feat.
J. Mayadev
